Supreme Court Will Decide if Federal Labeling Rules Protect Bayer from Roundup Lawsuits in U.S. States
The Supreme Court will rule if federal pesticide labels override state lawsuits over Roundup cancer claims, with major ag-law impacts.
On January 16, 2026, the U.S. Supreme Court agreed to hear a pivotal case involving Bayer's Roundup herbicide and whether federal pesticide labeling rules override state-level cancer lawsuits - a decision that could reshape legal exposure for ag chemical manufacturers nationwide. The ruling, expected later this year, could define how much legal weight EPA-approved labels carry and whether states can impose additional warning requirements under their own laws.
SCOTUS to Review Roundup Case on Federal Preemption Grounds
The case, Monsanto Company v. Durnell, centers on the scope of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and whether it preempts state "failure-to-warn" claims. Bayer, which acquired Monsanto, contends that if the EPA has approved a product's label, then manufacturers should be immune from state lawsuits alleging that additional health warnings were required - even if consumers later claim harm.
Thousands of plaintiffs across the U.S. have sued Bayer, alleging that long-term exposure to glyphosate - the active ingredient in Roundup - caused non-Hodgkin lymphoma. Bayer maintains that EPA's repeated findings that glyphosate is "not likely to be carcinogenic" should provide federal shield against such claims.
The legal challenge arises from a Missouri case brought by John Durnell, who was awarded $1.25 million in 2023 by a state jury on failure-to-warn grounds. The Missouri Court of Appeals upheld the ruling in 2025, prompting Bayer to seek Supreme Court intervention due to conflicting decisions in lower courts over whether FIFRA preempts state law.
Bayer CEO Bill Anderson welcomed the review, stating it's "time for the U.S. legal system to establish that companies should not be punished under state laws for complying with federal warning label requirements."
The company also cited support from U.S. Solicitor General John Sauer, who warned that allowing state-by-state warning requirements could erode the EPA's authority and fracture national labeling standards.
Environmental and consumer groups argue the opposite. The Center for Biological Diversity and Center for Food Safety say the Court's decision to hear the case could reduce public recourse and shield companies from evolving scientific scrutiny. They argue that EPA approval should not eliminate the right to sue if new evidence or adverse health effects emerge post-registration.
"The Court's review could limit access to the legal system for those harmed by chemicals like Roundup," said Lori Ann Burd, environmental health director at the Center for Biological Diversity.
The outcome of this case carries significant ramifications for U.S. agriculture, particularly in how future pesticide litigation is handled. A ruling in Bayer's favor could limit state-level challenges to federally registered products, simplifying compliance for manufacturers but potentially reducing liability pathways for injured parties.
Conversely, a ruling against Bayer could prompt relabeling or reformulation of ag chemicals, increased litigation risk for input suppliers, and varied labeling mandates between states - raising concerns for co-ops, ag retailers, and farm operators.
The Court is expected to issue a ruling by June 2026, which will be closely watched by industry stakeholders, environmental groups, and policymakers across the agricultural landscape.
